Pregnancy and cirrhosis

Liver Transplantation

Volumn 14, Issue 8, 2008, Pages 1081-1091

  Tan, Jennifer ^a   Surti, Bijal ^a   Saab, Sammy ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTIBIOTIC AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR; CEFOTAXIME; CEPHALOSPORIN; CIPROFLOXACIN; ENTECAVIR; FUROSEMIDE; GLUCOSE; LACTULOSE; LAMIVUDINE; NADOLOL; NEOMYCIN; NORFLOXACIN; OCTREOTIDE; OXYTOCIN; PENICILLAMINE; PREDNISONE; PROPRANOLOL; RIBAVIRIN; RIFAXIMIN; SCLEROSING AGENT; SPIRONOLACTONE; TELBIVUDINE; UNINDEXED DRUG; URSODEOXYCHOLIC ACID;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ANEMIA; ANEURYSM RUPTURE; ARTIFICIAL EMBOLISM; ASCITES; AUTOIMMUNE HEPATITIS; BACTERIAL PERITONITIS; BLOOD TRANSFUSION; BRADYCARDIA; BREAST FEEDING; BRONCHOSPASM; CESAREAN SECTION; DECOMPENSATED LIVER CIRRHOSIS; DIARRHEA; DRUG SAFETY; DYSPEPSIA; EAR DISEASE; ELECTROLYTE DISTURBANCE; ESOPHAGUS VARICES BLEEDING; FATIGUE; FETUS MORTALITY; FORCEPS DELIVERY; GASTROINTESTINAL DISEASE; HEART INFARCTION; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERTENSION; HYPOGLYCEMIA; HYPOTENSION; HYSTERECTOMY; INDIVIDUALIZATION; INTRAUTERINE GROWTH RETARDATION; KIDNEY DISEASE; LACTIC ACIDOSIS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER PERFUSION; MATERNAL MORTALITY; MOOD CHANGE; MYALGIA; NAUSEA; PANCREATITIS; PANCYTOPENIA; PATIENT CARE; PERIPHERAL ISCHEMIA; PERIPHERAL NEUROPATHY; PLACENTA PERFUSION; PORTAL HYPERTENSION; PORTOCAVAL SHUNT; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY OUTCOME; PREMATURITY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RADIATION HAZARD; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCLEROTHERAPY; SIDE EFFECT; SOLUTIO PLACENTAE; SPLEEN ARTERY; SPLENECTOMY; SPLENORENAL SHUNT; SPONTANEOUS ABORTION; STENT; TERATOGENICITY; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT CONTRAINDICATION; UTERUS BLEEDING; VEIN LIGATION; VIRUS HEPATITIS;

FEMALE; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 49649099022     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21572     Document Type: Review

References (125)

1. Russell MA, Craigo SD. Cirrhosis and portal hypertension in pregnancy. Semin Perinatol 1998;22:156-165.
2. Steven MM. Pregnancy and liver disease. Gut 1981;22: 592-614.
3. Benjaminov FS, Heatheote J. Liver disease in pregnancy. Am J Gastroenterol 2004;99:2479-2488.
4. Britton RC. Pregnancy and esophageal varices. Am J Surg 1982;143:421-425.
5. Pajor A, Lehoczky D. Pregnancy and extrahepatic portal hypertension. Gynecol Obstet Invest 1990;30:193-197.
6. Misra S, Sanyal AJ. Pregnancy in a patient with portal hypertension. Clin Liver Dis 1999;3:147-162.
7. Starkel P, Horsmans Y, Geubel A. Endoscopic band ligation: a safe technique to control bleeding esophageal varices in pregnancy. Gastrointestinal Endoscopy 1998;48: 212-214.
8. Kochhar R, Goenka MK, Mehta SK. Endoscopic sclerotherapy during pregnancy. Am J Gastroenterol 1990;85: 1132-1135.
9. O'Mahony S. Endoscopy in pregnancy. Best Pract Res Clin Gastroenterol. 2007;21:893-899.
10. Product Information: Sandostatin. East Hanover, NJ: Novartis Pharmaceuticals; 2000.
11. Lodato F, Cappelli A, Montagnani M, Colecchia A, Festi D, Azzaroli F, et al. Transjugular intrahepatic portosystemic shunt: a case report of rescue management of unrestrainable variceal bleeding in a pregnant woman. Dig Liver Dis 2008;40:387-390.
12. Parry RA, Glaze SA, Archer BR. The AAPM/RSNA physics tutorial for residents. Typical patient radiation doses in diagnostic radiology. Radiographics 1999;19:1289-1302.
13. Wildberger JE, Vorwerk D, Winograd R, Stargardt A, Busch N, Günther RW. New TIPS placement in pregnancy in recurrent esophageal varices hemorrhage-assessment of fetal radiation exposure [in German]. Rofo 1998; 169: 429-431.
14. Savage C, Patel J, Lepe MR, Lazarre CH, Rees CR. Transjugular intrahepatic por-tosystemic shunt creation for recurrent gastrointestinal bleeding during pregnancy. J Vasc Interv Radiol 2007;18:902-904.
15. Zeeman GG, Moise KJ. Prophylactic banding of severe esophageal varices associated with liver cirrhosis in pregnancy. Obstet Gynecol 1999;94:842.
16. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W, Practice Guidelines Corrunittee of the American Association for the Study of Liver Diseases, and Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007;46: 922-938.
17. Cheng YS. Pregnancy in liver cirrhosis and/or portal hypertension. Am J Obstet Gynecol 1977;128:812-822.
18. Schreyer P, Caspi E, Mohamad El-Hindi J, Eschchar J. Cirrhosis-pregnancy and delivery: a review. Obst Gynecol Surv 1982;37:304-312.
19. Heriot JA, Steven CM, Sattin RS. Elective forceps delivery and extradural anaesthesia in a primigravida with portal hypertension and oesaphageal varices. Br J Anes 1996; 76:325-327.
20. Smith JL, Graham DY. Variceal hemorrhage. A critical evaluation of survival analysis. Gastroenterology 1982; 82:968-973.
21. Fair J, Klein A, Feng T. Intraparturn orthotopic liver transplantation with successful outcome of pregnancy. Transplantation 1990;50:534-535.
22. Hamilton MI, Alcock R, Magis L, Mallett S, Rolles K, Burroughs AK. Liver transplantation during pregnancy. Transplant Proc 1993;25:2967-2968.
23. Laifer S, Darby M. Pregnancy and liver transplantation. Obstet Gynecol 1990;76:1083-1088.
24. Finlay DE, Foshager MC, Longley DG, Letourneau JG. Ischemic injury to the fetus after maternal liver transplantation. J Ultrasound Med 1994;13:145-148.
25. Pasha SF, Gloviczki P, Stanson AW, Kamath PS. Splanchnic artery aneurysms. Mayo Clin Proc 2007;82: 472-479.
26. Oyelese Y, Scorza WE, Mastrolia R, Smulian JC. Obstet Gynecol Clin North Am 2007;34:421-441.
27. Lee WM. Pregnancy in patients with chronic liver disease. Gastroenterol Clin North Am 1992;21:889-903.
28. Griebel CP, Halvorsen J, Golemon TB, Day AA. Management of spontaneous abortion. Am Farn Physician 2005; 72:1243-1250.
29. Pajor A, Lehoczky D. Pregnancy and extrahepatic portal hypertension. Gynecol Obstet Invest 1990;30:193-197.
30. Pajor A, Lehoczky D. Pregnancy in liver cirrhosis. Gynecol Obstet Invest 1994;38:45-50.
31. Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2006. Natl Vital Stat Rep 2007;56:1-18.
32. MacDorman MF, Hoyert DL, Martin JA, Munson ML, Hamilton BE. Fetal and perinatal mortality, 2003. Natl Vital Stat Rep 2007;55:1-18.
33. Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunization in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 2006;332:328-336.
34. Schaefer E, Koeppen H, Wirth S. Low level virus replication in infants with vertically transmitted falminant hepatitis and their anti-HBe positive mothers. Eur J Pediatr 1993;152:581-584.
35. Sookoian S. Effect of pregnancy on pre-existing liver disease: chronic viral hepatitis. Ann Hepatol 2006;5:190-197.
36. Soderstrom A, Norkrans G, Lindh M. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand J Infect Dis 2003;35:814-819.
37. Gervais A, Bacq Y, Bernuau J, Martinet M, Auperin A, Boyer N, et al. Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol 2000;32:293-299.
38. Wejstal R, Widell A, Norkrans G. HCV-RNA levels increase during pregnancy in women with chronic hepatitis C. Scand J Infect Dis 1998;30:111-113.
39. Paternoster DM, Santarossa C, Grella P, Patti G, Baldo V, Boccagni P, Floreani A. Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol 2001;96:2751-2754.
40. Wong S, Chan LY, Yu V, Ho L. Hepatitis B carrier and perinatal outcome in singleton pregnancy. Am J Perinatol 1999;16:485-488.
41. Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol 2005;43:771-775.
42. Su WH, Wang PH, Yuan CC, Chang SP. Fetal meconium peritonitis in the infant of a woman with fulminant hepatitis B. A case report. J Reprod Med 2002;47:952-954.
43. Paternoster DM, Fabris F, Palu G, Santarossa C, Bracciante R, Snijders D, et al. Intra-hepatic cholestasis of pregnancy in hepatitis C virus infection. Acta Obstet Gynecol Scand 2002;81:99-103.
44. Fontaine H, Nalpas B, Gillet A. Worsening of HCV-related hepatitis after pregnancy. Hepatology 2000;32:278A.
45. Jaffery T, Tariq N, Ayub R, Yawar A. Frequency of hepatitis C in pregnancy and pregnancy outcome. J Coll Physicians Surg Pak 2005;15:716-719.
46. Wang J, Zhu Q, Zhang X. Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis. Chin Med J (Engl) 2002;115:1510-1512.
47. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005;54:1-31.
48. Atkinson WL, Pickering LK, Schwartz B, Weniger BG, Iskander JK, Watson JC. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR Recomm Rep 2002;51:1-35.
49. European Paediatric Hepatitis C Virus Network. A significant sex-but not elective cesarean section-effect on mother-to-child transmission of hepatitis C virus infection. J Infect Dis 2005;192:1872-1879.
50. Paccagnini S, Principt N, Massironi E, Tanzi E, Romanò L, Muggiasca ML, et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pedtatr Infect Dis J 1995;14:195-199.
51. Committee on Obstetric Practice: American College of Obstetricians and Gynecologists. ACOG committee opinion. Breastfeeding and the risk of hepatitis C virus transmission. Number 220, August 1999. Int J Gynaecol Obstet 1999;66:307-308.
52. Wang JS, Zhu QR, Wang XH. Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier mothers. Int J Clin Pract 2003;57: 100-102.
53. Van Zonneveld M, Van Nunen AB, Niesters HG, De Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003;10:294-297.
54. Su GG, Pan KH, Zhao NF, Fang SH, Yang DH, Zhou Y. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004;10: 910-912.
55. Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 July 2007. Available at: http://www.apregistry.com. Accessed May 2008.
56. Ozaslan E, Yilmaz R, Simsek H, Tatar G. Interferon therapy for acute hepatitis C during pregnancy. Ann Pharmacother 2002;36:1715.
57. Steven MM, Buckley JD, Mackay IR. Pregnancy in chronic active hepatitis. Q J Med 1979;48:519-531.
58. Buchel E, Van Steenbergen W, Nevens F, Fevery J. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol 2002;97:3160-3165.
59. Heneghan MA, Norris SM, O'Grady JG, Harrison PM, McFarlane IG. Management and outcome of pregnancy in autoimmune hepatitis. Gut 2001;48:97-102.
60. Schramm C, Herkel J, Beuers U, Kanzler S, Galle PR, Lohse AW. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol 2006;101:556-560.
61. Werner M, Bjornsson E, Prytz H. Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding? Scand J Gastroenterol 2007;42:986-991.
62. Rayburn WF. Connective tissue disorders and pregnancy. Recommendations for prescribing. J Reprod Med 1998;43:341-349.
63. Korelitz BI. Inflammatory bowel disease and pregnancy. Gastroenterol Clin North Am 1998;27:213-224.
64. Poupon R, Chretien Y, Chazouilleres O, Poupon RE. Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis. J Hepatol 2005;42:418-419.
65. Heathocote JE. AASLD practice guidelines: management of primary biliary cirrhosis. Hepatology 2000;31:1005.
66. Rudi J, Schonig T, Stremmel W. Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy. Z Gastroenterol 1996;34:188-191.
67. Serreau R, Komiha M, Blanc F, Guillot, F, Jacqz-Aigrain E. Neonatal seizures associated with maternal hydroxyzine hydrochloride in late pregnancy. Reprod Toxicol 2005;20:573-574.
68. Shimono N, Ishibashi H, Ikematsu H, Kudo J, Shirahama M, Inaba S, et al. Fulminant hepatic failure during perinatal period in a pregnant woman with Wilson's disease. Gastroenterol Jpn 1991;26:69-73.
69. Sternlieb I. Wilson's disease and pregnancy. Hepatology 2000;31:531-532.
70. Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology 2003:37:1475-1492.
71. Lefkowitch JH, Rushton AR, Feng-Chen KC. Hepatic fibrosis in fetal alcohol syndrome. Pathologic similarities to adult alcoholic liver disease. Gastroenterology 1983; 85:951-957.
72. Armenti VT, Radomski JS, Moritz MJ, Gaughan WJ, Gulati R, McGrory CH, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 2005:69-83.
73. Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti VT. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 2006;82: 1698-1702.
74. Nagy S, Bush MC, Berkowitz R, Fishbein TM, Gomez-Lobo V. Pregnancy outcome in liver transplant recipients. Obstet Gynecol 2003;102:121-128.
75. McKay DB, Josephson MA. Reproduction and transplantation: report on the AST consensus conference on reproductive issues and transplantation. Am J Transpl 2005; 5:1592-1599.
76. Ferris TF. How should hypertension during pregnancy be managed? An internist's approach. Med Clin N Am 1984; 68:491-503.
77. Vert P, Broquaire M, Legagneur M, Morselli PL. Pharmacokinetics of furosemide in neonates. Eur J Clin Pharmacol 1982;22:39-45.
78. Witter FR, King TM, Blake DA. Adverse effects of cardiovascular drug therapy on the fetus and neonate. Obstet Gynecol 1981;58:100S-105S.
79. Hecker A, Hasan SH, Neumann F. Effect of spironolactone on sexual differentiation of rat fetuses. Acta Endocrinol 1978;87:32.
80. Doany W, Brinkman CR. Antithypertensive drugs in pregnancy. Perinatal Pharmacol 1987;14:783-805.
81. Drayer JI, Zegarelli EC. Hypertension and pregnancy. Cardiovasc Clin 1989;19:97-111.
82. Levitan AA, Manion JC. Propranolol therapy during pregnancy and lactation. Am J Cardiol 1973;247:87-93.
83. Anderson PO, Salter FJ. Propranolol during pregnancy and lactation. Am J Cardiol 1976;37:325.
84. Coltart DJ, Shand DG. Plasma propranolol levels in the quantitative assessment of beta-adrenergic blockade in man. Br Med J 1970;3:731-734.
85. Taylor EA, Turner P. Antihypertensive therapy with propranolol during pregnancy and lactation. Postgrad Med J 1981;57:427-430.
86. Bauer JH, Pape B, Zajicek J, Groshong T. Propranolol in human plasma and breast milk. Am J Cardiol 1979;43: 860-862.
87. Karlberg B, Lundberg D, Aberg H. Excretion of propranolol in human breast milk. Acta Pharmacol Toxicol 1974; 34:222.
88. Devlin RG, Duchin KL. Nadolol in human serum and breast milk. Br J Clin Pharmacol 1981;12:393-396.
89. Atkinson HC, Begg EJ, Darlow BA. Drugs in human milk. Clinical pharmacokinetic considerations. Clin Pharmacokinet 1988;14:217-240.
90. Anderson PO. Drug use during breast-feeding. Clin Pharm 1991;10:594-624.
91. Avery GS, Davies EF, Brogden RN. Lactulose: a review therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action in portal-systemic encephalopathy. Drugs 1972;4:7-48.
92. Product Information: Xifaxan ™, Rifaximin. Raleigh, NC: Salix Pharmaceuticals; 2004.
93. Holdiness MR. Teratology of the antituberculosis drugs. Early Hum Dev 1987:15:61-74.
94. Conway N, Birt BD. Streptomycin in pregnancy. effect on the foetal ear. Br Med J 1965;2:160-163.
95. Jones HC. Intrauterine ototoxicity. A case report and review of the literature. J Natl Med Assoc 1973,65:201-203.
96. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001;108:776-789.
97. Schwarz RH. Considerations of antibiotic therapy during pregnancy. Obstet Gynecol 1981;58:95S-99S.
98. Weinstein AJ. Treatment of bacterial infections in pregnancy. Drugs 1979;17:56-65.
99. Berkowitz RL, Coustan DR, Mochizitki TK. Handbook for Prescribing Medications During Pregnancy. Boston, MA: Little, Brown & Company; 1981.
100. Matsuda S. Transfer of antibiotics into maternal milk. Biol Res Preg Perinatol 1984;5:57-60.
101. Bennett PN, ed. Drugs and Human Lactation. 2nd ed. Amsterdam, The Netherlands: Elsevier Science; 1996.
102. Savoia MC. Bacterial, fungal, and parasitic disease during pregnancy. In: Burrows GN, Ferris TF, eds. Medical Complications During Pregnancy. 4th ed. Philadelphia, PA: WB Saunders; 1995.
103. Cunningham FG, MacDonald PC, Grant NF, Leveno, KF, Gilstrap LC III, eds. Williams Obstetrics. 19th ed. Norwalk, CT: Appleton & Lange; 1993.
104. Bomford JAL, Ledger JC, O'Keefe B, Reiter C. Ciprofloxacin use during pregnancy. Drugs 1993;45:461-462.
105. Loebstein R, Addis A, Ho E, Andreou R, Sage S, Donnenfeld AE, et al. Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother 1998; 42:1336-1339.
106. Berkovitch M, Pastuszak A, Gazarian M, Lewis M, Koren G. Safety of the new quinolones, in pregnancy. Obstet Gynecol 1994;84:535-538.
107. Wilton LV, Pearce GL, Martin RM, Mackay FJ, Mann RD. The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol 1998; 105:882-889.
108. Gardner D, Gabbe S, Harter C. Simultaneous concentrations of ciprofloxacin in breast milk and in serum in mother and breast-fed infant. Clin Pharm 1992:11:352-354.
109. Giamarellou H, Kolokythas E, Petrikkos G, Gazis J, Aravantinos D, Sfikakis P. Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med 1989:87:49S-51S.
110. Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the united states. Available at: http://aidsinfo.nih.gov/contentfiles/ perinatal-gl.pdf Accessed May 2008.
111. Blanche S, Tardieu M, Rustin P, Slama A, Barret B, Firtion G, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999;354:1084-1089.
112. Ristola M, Salo E, Animälä P, Suni J. Combined stavudine and lamivudine during pregnancy [letter]. AIDS 1999:13:285.
113. Product Information: Epivir-HBV®, Lamivudine. Research Triangle Park, NC: GlaxoSmithKline; 2004.
114. Regierer AC, Schulz CO, Kuehnhardt D, Flath B, Possinger K. Interferon-alpha therapy for chronic myeloid leukemia during pregnancy. Am J Hematol 2006;81:149-150.
115. Fritz M, Vats K, Goyal RK. Neonatal lupus and IUGR following alpha-interferon therapy during pregnancy. J Perinatol 2005;25:552-554.
116. Product Information: Hepsera(TM) (Adefovir Dipivoxil). Foster City, CA: Gilead Sciences; 2002.
117. Product Information: Baraclude(TM) Oral Tablets, Oral Solution, Entecavir Oral Tablets, Oral Solution. Princeton, NJ: Bristol-Myers Squibb; 2007.
118. Product Information: Tyzeka(TM) Oral Tablets, Telbivudine Oral Tablets. East Hanover, NJ: Novartis. Pharmaceuticals; 2006.
119. Product Information: Copegus (R), Ribavirin Tablets. Nutley, NJ: Roche Pharmaceuticals; 2002.
120. Polifka JE, Friedman JM. Teratogen update: azathioprine and 6-mercaptopurine. Teratology 2002;65:240-261.
121. Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med 2000; 160:610-619.
122. Dupont P, Irion O, Beguin F. Pregnancy in a patient with treated Wilson's disease: a case report. Am J Obstet Gynecol 1990; 163(pt 1): 1527-1528.
123. Mjolnerod, OK, Dommerud, SA, Rasmussen, K, Gjeruldsen, ST. Congenital connective-tissue defect probably due to D-penicillamine treatment in pregnancy. Lancet 1971;1:673.
124. Product Information: Syprine (TM) (Trientine Hydrochloride). Whitehouse Station, NJ: Merck & Company; 2001.
125. Product Information: Questran (TM). Spring Valley, NY: Par Pharmaceutical; 2006.